Agenus Company Profile (NASDAQ:AGEN)

About Agenus

Agenus logoAgenus Inc. (Agenus) is an immuno-oncology company. The Company is engaged in discovering and developing treatments for patients with cancer. Its approaches are driven by platforms and programs, which include antibody discovery platform, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage and AutoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company has a portfolio of programs in various stages of development, including a series of antibodies in discovery and pre-clinical and clinical development, Prophage vaccine, a Heat Shock Protein (HSP)-based vaccine candidate for a form of brain cancer that has completed Phase II trials, and a number of QS-21 Stimulon-containing vaccine candidates in late stage development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: AGEN
  • CUSIP: 00847G70
Key Metrics:
  • Previous Close: $5.85
  • 50 Day Moving Average: $5.38
  • 200 Day Moving Average: $4.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.87
  • P/E Growth: 0.00
  • Market Cap: $511.91M
  • Outstanding Shares: 86,912,000
  • Beta: 2.23
Additional Links:
Companies Related to Agenus:

Analyst Ratings

Consensus Ratings for Agenus (NASDAQ:AGEN) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.33 (87.64% upside)

Analysts' Ratings History for Agenus (NASDAQ:AGEN)
Show:
DateFirmActionRatingPrice TargetDetails
8/23/2016Jefferies GroupReiterated RatingBuyView Rating Details
7/31/2016HC WainwrightReiterated RatingBuy$10.00View Rating Details
7/28/2016Maxim GroupReiterated RatingBuy$7.00View Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$17.00 -> $15.00View Rating Details
12/31/2015Oppenheimer Holdings Inc.Reiterated RatingPositive -> Outperform$14.00View Rating Details
9/10/2015William BlairReiterated RatingBuyView Rating Details
7/27/2015MLV & Co.Reiterated RatingBuy$9.00 -> $11.00View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Agenus (NASDAQ:AGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2016        
7/28/2016Q216($0.34)($0.33)$5.12 million$6.59 millionViewListenView Earnings Details
4/28/2016Q116($0.23)($0.37)$5.16 millionViewListenView Earnings Details
3/3/2016Q415($0.17)($0.18)$9.39 million$7.64 millionViewListenView Earnings Details
10/27/2015Q315($0.15)($0.16)$7.56 millionViewListenView Earnings Details
7/23/2015Q215($0.15)($0.44)$5.71 million$6.38 millionViewListenView Earnings Details
4/23/2015Q115($0.01)($0.28)$11.66 million$3.95 millionViewN/AView Earnings Details
2/26/2015Q414($0.16)($0.41)$1.62 millionViewN/AView Earnings Details
10/31/2014Q314($0.15)($0.13)$1.96 million$1.56 millionViewN/AView Earnings Details
7/24/2014Q214($0.17)($0.12)$3.07 millionViewN/AView Earnings Details
5/8/2014Q114($0.13)($0.01)$0.55 million$0.72 millionViewN/AView Earnings Details
3/5/2014Q413($0.24)($0.16)$870.00 million$393.00 millionViewN/AView Earnings Details
10/24/2013Q313($0.27)($0.24)$736.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013($0.21)($0.40)ViewN/AView Earnings Details
2/28/2013Q4 2012($0.24)($0.23)$0.72 million$1.09 millionViewN/AView Earnings Details
7/28/2011($0.05)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Agenus (NASDAQ:AGEN)
Current Year EPS Consensus Estimate: $-1.27 EPS
Next Year EPS Consensus Estimate: $-1.24 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.18)($0.18)($0.18)
Q2 20161($0.39)($0.39)($0.39)
Q3 20161($0.44)($0.44)($0.44)
Q4 20161($0.47)($0.47)($0.47)
Q1 20171($0.24)($0.24)($0.24)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.25)($0.25)($0.25)
Q4 20171($0.25)($0.25)($0.25)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Agenus (NASDAQ:AGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Agenus (NASDAQ:AGEN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2016Garo H ArmenCEOBuy100,000$3.18$318,000.00View SEC Filing  
5/5/2016Ozer BaysalInsiderBuy2,250$3.10$6,975.00View SEC Filing  
3/7/2016Garo H ArmenCEOBuy200,000$4.03$806,000.00View SEC Filing  
12/29/2015Garo H. ArmenCEOSell219,576$4.59$1,007,853.84View SEC Filing  
12/28/2015Garo H. ArmenCEOSell134,352$4.60$618,019.20View SEC Filing  
9/25/2015Charles Evan BallantyneCFOBuy10,000$5.05$50,500.00View SEC Filing  
9/25/2015Garo H ArmenCEOBuy100,000$5.03$503,000.00View SEC Filing  
4/29/2015Shahzad MalikDirectorSell1,107,377$7.11$7,873,450.47View SEC Filing  
1/9/2015Qvt Associates Gp LlcMajor ShareholderSell2,343,630$5.31$12,444,675.30View SEC Filing  
1/23/2014Karen ValentineVPSell2,850$3.50$9,975.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Agenus (NASDAQ:AGEN)
DateHeadline
News IconAgenus Inc. (NASDAQ:AGEN) earnings expectations - The Independent Republic (NASDAQ:AGEN)
theindependentrepublic.com - August 25 at 3:22 PM
News IconTop Earnings to Watch for: Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 25 at 3:22 PM
News IconGlobal vaccine adjuvants market research report - forecast to 2027 explored in latest research (NASDAQ:AGEN)
www.whatech.com - August 24 at 11:39 AM
capitalcube.com logoETF’s with exposure to Agenus, Inc. : August 23, 2016 (NASDAQ:AGEN)
www.capitalcube.com - August 23 at 3:20 PM
News Icon2 Under-the-Radar Cancer Stocks That are in the Bargain Bin Right Now (NASDAQ:AGEN)
www.biospace.com - August 20 at 8:14 AM
News IconSell-side is Weighing in on Agenus Inc. (NASDAQ:AGEN) Earnings - Post News (NASDAQ:AGEN)
www.kentuckypostnews.com - August 19 at 11:45 AM
fool.com logo2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now (NASDAQ:AGEN)
www.fool.com - August 18 at 11:41 AM
News IconNews review of 2 biotech stocks: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 16 at 3:22 PM
News IconVaccine Adjuvants Market worth 769.4 Million USD by 2021 (NASDAQ:AGEN)
www.emailwire.com - August 15 at 10:37 AM
News IconHot Biotech Stocks Recap: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Agenus Inc. (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 12 at 3:32 PM
finance.yahoo.com logoAGENUS INC Financials (NASDAQ:AGEN)
finance.yahoo.com - August 12 at 3:32 PM
finance.yahoo.com logoWhy Agenus (AGEN) Stock Might be a Great Pick (NASDAQ:AGEN)
finance.yahoo.com - August 12 at 11:55 AM
feeds.benzinga.com logoWatch These 7 Huge Call Purchases In Friday Trade (NASDAQ:AGEN)
feeds.benzinga.com - August 12 at 2:53 AM
prnewswire.com logoResearch Report Initiation on Biotech Stocks -- Agenus, ProNAi Therapeutics, Vanda Pharma, and Genocea Biosciences (NASDAQ:AGEN)
www.prnewswire.com - August 11 at 12:34 PM
capitalcube.com logoETF’s with exposure to Agenus, Inc. : August 11, 2016 (NASDAQ:AGEN)
www.capitalcube.com - August 11 at 12:34 PM
capitalcube.com logoAgenus, Inc. :AGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:AGEN)
www.capitalcube.com - August 10 at 3:41 PM
fortune.com logoLooking At Recent Analyst Ratings: Eclipse Resources Corp (NYSE:ECR), Agenus Inc (NASDAQ:AGEN) - Review Fortune (NASDAQ:AGEN)
reviewfortune.com - August 9 at 3:59 PM
streetupdates.com logoUpdated Analysts Rating Report: Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN)
www.streetupdates.com - August 8 at 8:09 AM
tradecalls.org logoJefferies Maintains Agenus Inc to Buy with Price Target $7.00 ... - Trade Calls (NASDAQ:AGEN)
www.tradecalls.org - August 8 at 8:09 AM
streetupdates.com logoTraders Focused Stocks: Agenus Inc. (NASDAQ:AGEN) , Edwards ... - Street Updates (NASDAQ:AGEN)
www.streetupdates.com - August 5 at 8:46 PM
equities.com logoAgenus Inc. (AGEN) Jumps 9.03% on August 05 - Equities.com (NASDAQ:AGEN)
www.equities.com - August 5 at 8:46 PM
News IconAgenus Inc (NASDAQ:AGEN): That’s How Our Members Are Already up 25% In 3-Week, Buy Call At $4.96 (NASDAQ:AGEN)
www.marketnewscall.com - August 5 at 3:22 PM
News IconDiscover the Global vaccine adjuvants market forecast to 2021 (NASDAQ:AGEN)
www.whatech.com - August 5 at 11:45 AM
News IconGlobal Vaccine Adjuvants Sales Market Report to 2021: Brenntag Biosector, Seppic, CSL Limited, Agenus Inc (NASDAQ:AGEN)
www.medgadget.com - August 5 at 11:45 AM
biz.yahoo.com logoAGENUS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:AGEN)
biz.yahoo.com - August 4 at 9:05 PM
fortune.com logoAgenus Inc. (NASDAQ:AGEN): Updated Analyst Ratings - Review Fortune (NASDAQ:AGEN)
reviewfortune.com - August 4 at 11:53 AM
News IconTime To Put On The Watch List? - Agenus Inc. (NASDAQ:AGEN), Halozyme Therapeutics, Inc. (NASDAQ:HALO) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 4 at 11:53 AM
streetupdates.com logoAnalyst's Focused Stocks: Horizon Pharma plc (NASDAQ:HZNP) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN)
www.streetupdates.com - August 4 at 11:53 AM
finance.yahoo.com logoWill Agenus (AGEN) Continue to Surge Higher? (NASDAQ:AGEN)
finance.yahoo.com - August 4 at 11:53 AM
fortune.com logoHere Are Research Reports Worth Watching: Agenus Inc (NASDAQ:AGEN), Immunomedics, Inc. (NASDAQ:IMMU) - Review Fortune (NASDAQ:AGEN)
reviewfortune.com - August 3 at 3:25 PM
streetupdates.com logoSummary of Analysts Rating: AbbVie Inc. (NYSE:ABBV) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN)
www.streetupdates.com - August 2 at 3:21 PM
News IconBiotechnology Stocks in Focus: Hemispherx BioPharma, Inc ... - Post Registrar (NASDAQ:AGEN)
postregistrar.com - August 2 at 3:21 PM
News IconAnalyst Recommendation Worth Stating Today: Agenus Inc (NASDAQ:AGEN) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 2 at 8:08 AM
finance.yahoo.com logoEdited Transcript of AGEN earnings conference call or presentation 28-Jul-16 3:00pm GMT (NASDAQ:AGEN)
finance.yahoo.com - August 2 at 8:08 AM
News IconTime To Put On The Watch List? - Agenus Inc. (NASDAQ:AGEN), XOMA Corporation (NASDAQ:XOMA) - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - August 1 at 3:21 PM
News IconHC Stocks in Drift: Agenus Inc (NASDAQ:AGEN) Allergan plc Ordinary Shares (NYSE:AGN) - share market updates (press release) (NASDAQ:AGEN)
sharemarketupdates.com - August 1 at 3:21 PM
streetupdates.com logoAnalysts Ranking Previews: Cigna Corporation (NYSE:CI) , Agenus Inc. (NASDAQ:AGEN) - Street Updates (NASDAQ:AGEN)
www.streetupdates.com - August 1 at 8:08 AM
fortune.com logoIdentifying Analyst Research Reports To Consider: Agenus Inc (NASDAQ:AGEN), XOMA Corp (NASDAQ:XOMA) - Review Fortune (NASDAQ:AGEN)
reviewfortune.com - August 1 at 8:08 AM
investornewswire.com logoWill Agenus Inc. (NASDAQ:AGEN) Surprise Analysts? - Investor Newswire (NASDAQ:AGEN)
www.investornewswire.com - July 30 at 3:27 PM
breakingfinancenews.com logoJefferies & Co disclosed (NASDAQ:AGEN) Agenus Inc, increasing its price target to $7 earlier today (NASDAQ:AGEN)
breakingfinancenews.com - July 29 at 8:52 PM
News IconBiotech Stocks To Put On Your Watch List: Agenus Inc. (NASDAQ:AGEN), Adverum Biotechnologies, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:AGEN)
voiceregistrar.com - July 29 at 3:21 PM
News IconStock Analysis review: Agenus Inc. (NASDAQ:AGEN) - News Oracle (NASDAQ:AGEN)
www.newsoracle.com - July 29 at 3:21 PM
equities.com logoAgenus Inc. (AGEN) Jumps 9.13% on July 28 - Equities.com (NASDAQ:AGEN)
www.equities.com - July 29 at 3:21 PM
smarteranalyst.com logoHC Wainwright Weighs In on Agenus Inc (AGEN) Following 2Q:16 Update - Smarter Analyst (NASDAQ:AGEN)
www.smarteranalyst.com - July 29 at 3:21 PM
finance.yahoo.com logoAgenus (AGEN) Posts Narrower than Expected Loss in Q2 (NASDAQ:AGEN)
finance.yahoo.com - July 29 at 9:47 AM
biz.yahoo.com logoAgenus Inc Earnings Call (Q2 2016) (NASDAQ:AGEN)
biz.yahoo.com - July 28 at 4:20 PM
twst.com logoAgenus Inc.: Agenus Reports Second Quarter 2016 Financial Results and Operational Progress - The Wall Street Transcript (NASDAQ:AGEN)
www.twst.com - July 28 at 11:59 AM
biz.yahoo.com logoAgenus Inc Earnings Call scheduled for 11:00 am ET today (NASDAQ:AGEN)
biz.yahoo.com - July 28 at 11:00 AM
finance.yahoo.com logoAgenus (AGEN) Reports Narrower-than-Expected Q2 Loss (NASDAQ:AGEN)
finance.yahoo.com - July 28 at 10:43 AM
publicnow.com logoAgenus Reports Second Quarter 2016 Financial Results and Operational Progress (NASDAQ:AGEN)
www.publicnow.com - July 28 at 9:08 AM

Social

Agenus (NASDAQ:AGEN) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff